Friday, Oct 02, 2020 | Last Update : 02:05 AM IST

192nd Day Of Lockdown

Maharashtra1400922110442637056 Andhra Pradesh7002356365085869 Karnataka6118374924128994 Tamil Nadu6032905463359586 Uttar Pradesh4031013468595864 Delhi2827522506135401 West Bengal2603242287555017 Odisha222734190080912 Kerala204242131048772 Telangana1936001634071135 Bihar178882164537888 Assam169985139977655 Gujarat1332191132403417 Rajasthan1288591077181441 Haryana1237821059901307 Madhya Pradesh117588932382207 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880
  World   Americas  26 May 2020  WHO suspends testing hydroxychloroquine on virus patients

WHO suspends testing hydroxychloroquine on virus patients

REUTERS
Published : May 26, 2020, 12:16 pm IST
Updated : May 26, 2020, 12:16 pm IST

Hydroxycholoroquine has been touted by Donald Trump and many others as a possible treatment for COVID-19

A chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP)
 A chemist holds a pack of hydroxychloroquine tablets in Mumbai, India. (AP)

Geneva: The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.

Hydroxychloroquine has been touted by Donald Trump and many others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection.

 

“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” Tedros told an online briefing.

He said the other arms of the trial - a major international initiative to hold clinical tests of potential treatments for the virus - were continuing.

The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.

Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”.

 

Tags: hydroxychloroquine, coronavirus, covid-19, trump, world health organization, malaria drug, india